Anionic liposomes prepared without organic solvents for effective siRNA delivery. 2023

Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
Department of Clinical Pharmacy, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.

Currently, organic solvents are necessary for the preparation of anionic liposomes for siRNA delivery. The removal of organic solvent is time-consuming and the residual organic solvent is not only a hidden danger, but also affects the stability of anionic liposomes. Glycerol, which is physiologically compatible and does not need to be removed, is used to promote the dispersion of lipids and the formation of anionic liposomes. Additionally, the preparation process is simple and not time-consuming. The results showed that anionic liposomes, which were typically spherical with a particle size of 188.9 nm were successfully prepared with glycerol. And with the help of Ca2+ , siRNA was encapsulated in anionic liposomes. The highest encapsulation efficiency at 2.4 mM Ca2+ reached 91%. And the formation of calcium phosphate could promote the endosomal escape of siRNA effectively. The results from cell viability showed that the anionic liposomes had no obvious cytotoxicity. It was also verified that anionic liposomes could improve the resistance of siRNA against degradation. Additionally, siRNA delivered by anionic liposomes could play an effective role in knockout. Therefore, anionic liposomes prepared with glycerol will be a safe and effective delivery platform for siRNA and even other nucleic acid drugs.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D005990 Glycerol A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent. 1,2,3-Propanetriol,Glycerin,1,2,3-Trihydroxypropane,Glycerine
D012997 Solvents Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed) Solvent
D034741 RNA, Small Interfering Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions. RNA, Scan,Repeat-Associated siRNA,Scan RNA,Small Scan RNA,Trans-Acting siRNA,siRNA,siRNA, Repeat-Associated,siRNA, Trans-Acting,Short Hairpin RNA,Short Interfering RNA,Small Hairpin RNA,Small Interfering RNA,scnRNA,shRNA,tasiRNA,Hairpin RNA, Short,Hairpin RNA, Small,Interfering RNA, Short,Interfering RNA, Small,RNA, Short Hairpin,RNA, Short Interfering,RNA, Small Hairpin,RNA, Small Scan,Repeat Associated siRNA,Scan RNA, Small,Trans Acting siRNA,siRNA, Repeat Associated,siRNA, Trans Acting

Related Publications

Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
July 2016, Journal of visualized experiments : JoVE,
Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
June 2011, Journal of controlled release : official journal of the Controlled Release Society,
Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
January 2018, Current pharmaceutical design,
Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
January 2014, Current drug metabolism,
Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
January 2015, Journal of drug targeting,
Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
December 2009, Journal of controlled release : official journal of the Controlled Release Society,
Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
March 2011, Bioconjugate chemistry,
Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
October 2018, International journal of pharmaceutics,
Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
April 1973, Biochimica et biophysica acta,
Xiu Han, and Yan Lu, and Zhaoluo Xu, and Yanan Chu, and Xueping Ma, and Haiping Wu, and Bingjie Zou, and Guohua Zhou
June 2020, Advanced materials (Deerfield Beach, Fla.),
Copied contents to your clipboard!